Shares in Align Technology (NSDQ:ALGN) rose today after the dental-focused device maker posted Street-beating Q1 earnings alongside a number of other updates, including a clearance from China’s FDA, an update on a legal spat with SmileDirectClub and multiple product launches. The San Jose, Calif.-based company posted profits of $ 95.9 million, or $ 1.17 per share, on sales of $ 436.9 million for the three months ended March 31, for bottom-line growth of 38.1% while sales grew 40.8% compared with the same period last year. Align Technology’s earnings per share were ahead of the 98¢ consensus on Wall Street, where analysts expected too see sales of $ 408.3 million, which the company handily topped. “I’m pleased to report better than expected first quarter results and a strong star…
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
